Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Cancer Prev Res (Phila). 2009 Mar 31;2(4):322–329. doi: 10.1158/1940-6207.CAPR-09-0005

Fig. 4.

Fig. 4

Treatment with celecoxib led to a significant increase in urinary LTE4 levels among subjects with high baseline PGE-M levels. For individuals with high PGE-M, the median (range) magnitude of change induced by celecoxib was 34 pg/mg Cr (-208, 4673), p=0.03. For individuals with low PGE-M, the median (range) magnitude of change induced by celecoxib was -8 pg/mg Cr (-244, 229), p=0.96.